A tuberculin skin test (TST) or interferon-gamma releasing assay (IGRA) can substitute for LTBI testing; however, these assays are incapable of discriminating between LTBI and active TB or measuring progression to active TB, which creates problems when implementing TB elimination strategies in areas with high TB prevalence (8–11). Here, IFNG is linked to tuberculosis.